Medicare demonstration shows accountability can save money

Thompson, Cheryl A.
February 2011
American Journal of Health-System Pharmacy;2/1/2011, Vol. 68 Issue 3, p190
Academic Journal
The article discusses the benefits of the Physician Group Practice Demonstration to the health care group participant or accountable care organizations (ACOs) in the U.S. It states that participants might receive more of the fee-for-service payment. The demonstration encourages coordination of the provided health care, invest in administrative structures, and process efficient delivery of service. It also mentions that it will reward the physicians for improving the health of patients.


Related Articles

  • McKesson settling up $190 million payment latest in drug-price flap. Carlson, Joe // Modern Healthcare;4/30/2012, Vol. 42 Issue 18, p14 

    The article reports that drug wholesaler and information technology provider McKesson Corp. has agreed to pay 190 million U.S. dollars in April 2012 to settle False Claims Act liability regarding claims that it had misreported the markups on certain branded drugs that it distributes to...

  • Looking for a solution: Pressure grows for permanent fix to doc pay formula. Daly, Rich // Modern Healthcare;11/7/2011, Vol. 41 Issue 45, p12 

    The article discusses the plan to fix the formula for physician payment. The Obama administration, it says, finalized the payment reduction at 27.4% which is lower than the expected 29.5% by physicians that led to growing pressure among provider groups on overhauling their physician payment...

  • OPPS continues ASP-plus-6% reimbursement rate for 2014. Traynor, Kate // American Journal of Health-System Pharmacy;1/15/2014, Vol. 71 Issue 2, p90 

    The article reports on the continuance of 2014 Medicare reimbursement for drugs from hospitals at the 2013 rate, which is the average sale price (ASP) plus 6%. The rate reportedly appears in the final rule for the 2014 Medicare hospital outpatient prospective payment system (OPPS). It notes that...

  • Medicare finalizes ASP-plus-six reimbursement rate for outpatient drugs. Traynor, Kate // American Journal of Health-System Pharmacy;Jan2013, Vol. 70 Issue 1, p11 

    The article offers drugs' average sale price (ASP) news briefs as of January 1, 2013. The reimbursement rate is published in the November 15 Federal Register which will appear in the Centers for Medicare and Medicaid Services (CMS) final rule for the 2013 Medicare hospital outpatient prospective...

  • Prop. 61 Can Set National Model. DeMoro, RoseAnn // National Nurse;May/Jun2016, Vol. 112 Issue 3, p13 

    The article offers information on the importance of Prop. 61, a drug price standards initiative which aims to lower drug prices in the U.S. Topics mentioned include the increase in the average price of brand-name drugs in the country, the impact of predatory pricing on state governments, and...

  • Latest physician data spotlight how Medicare pays for drugs. Herman, Bob // Modern Healthcare;6/8/2015, Vol. 45 Issue 23, p0012 

    The article focuses on costs of drugs paid by Medicare insurance program of the U.S. government in 2013, with reference to data released by the U.S. Center for Medicare and Medicaid Services (CMS). It states that the most of the patients' bill paid by the healthcare program were related to drugs...

  • A better way to save Medicare. Hahn, Kurt // Modern Healthcare;7/11/2011, Vol. 41 Issue 28, p37 

    A letter to the editor is presented in response to the article "Senators offer bill to reduce Medicare spending," in the June 28, 2011 issue.

  • How to get paid for drugs administered in the office. Painter, Ray; Painter, Mark // Urology Times;3/1/2014, Vol. 42 Issue 3, p32 

    The article shares best practices for billing for drugs administered in the office. Suggestions include alerting the office that there is a patient's appointment to receive a drug, verifying health insurance, and carrying an inventory of the drug. Other recommendations include verifying that...

  • Painful side effects. Carlson, Joe // Modern Healthcare;4/15/2013, Vol. 43 Issue 15, p32 

    The article focuses on the impact of drug-abuse problems on the efforts to address anti-fraud in Medicare Part D in the U.S. It describes the prevalence of drug abuse among Medicare beneficiaries, along with the provisions of Part D drug coverage to monitor fraud. The systemic flaws in Medicare...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics